Additionally, they identified therapeutically targetable checkpoint receptor-ligand interactions and demonstrated that tumor-associated macrophages are major contributors to programmed death ligand 1 (PD-L1) expression and other immune checkpoint ligands within the HNSCC TME.26 This evidence concerns the gene CD274 and neoplasm.